Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomomi Fujii

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
In Vivo (Athens, Greece)|October 30, 2024
Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER TrialMakito Miyake, Nobumichi Tanaka, Kenta Ohnishi, et al.
Current Urology|November 23, 2023
Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancerYusuke Iemura, Makito Miyake, Shinji Fukui, et al.
Japanese Journal of Clinical Oncology|October 31, 2019
Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosteroneYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 11, 2021
Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidilFumisato Maesaka, Nobumichi Tanaka, Yasushi Nakai, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 1, 2021
Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specifiedHiroe Itami, Hirokazu Nakamine, Masayuki Kubo, et al.
International Journal of Surgical Pathology|July 5, 2018
Immunohistochemical Reappraisal Regarding the Frequency of Primary Salivary Gland Follicular LymphomaHiroe Itami, Hirokazu Nakamine, Maiko Takeda, et al.
Case Reports in Urology|January 24, 2023
Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting AgentMakito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, et al.
Research and Reports in Urology|April 3, 2019
Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient's age and prostate volumeShunta Hori, Nobumichi Tanaka, Yasushi Nakai, et al.
Biochemical and Biophysical Research Communications|August 16, 2014
Regulation of IL-6 and IL-8 production by reciprocal cell-to-cell interactions between tumor cells and stromal fibroblasts through IL-1α in ameloblastomaTakao Fuchigami, Toshiro Kibe, Hirofumi Koyama, et al.
Clinical and Translational Radiation Oncology|December 15, 2018
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancerKenta Onishi, Nobumichi Tanaka, Makito Miyake, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
In Vivo (Athens, Greece)|October 30, 2024
Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER TrialMakito Miyake, Nobumichi Tanaka, Kenta Ohnishi, et al.
Current Urology|November 23, 2023
Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancerYusuke Iemura, Makito Miyake, Shinji Fukui, et al.
Japanese Journal of Clinical Oncology|October 31, 2019
Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosteroneYasushi Nakai, Nobumichi Tanaka, Isao Asakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 11, 2021
Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidilFumisato Maesaka, Nobumichi Tanaka, Yasushi Nakai, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|July 1, 2021
Diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion. Close resemblance of its clinicopathological features to intravascular large B-cell lymphoma, but not to DLBCL-not otherwise specifiedHiroe Itami, Hirokazu Nakamine, Masayuki Kubo, et al.
International Journal of Surgical Pathology|July 5, 2018
Immunohistochemical Reappraisal Regarding the Frequency of Primary Salivary Gland Follicular LymphomaHiroe Itami, Hirokazu Nakamine, Maiko Takeda, et al.
Case Reports in Urology|January 24, 2023
Response of Patients with Taxane-Refractory Advanced Urothelial Cancer to Enfortumab Vedotin, a Microtubule-Disrupting AgentMakito Miyake, Nobutaka Nishimura, Tatsuki Miyamoto, et al.
Research and Reports in Urology|April 3, 2019
Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient's age and prostate volumeShunta Hori, Nobumichi Tanaka, Yasushi Nakai, et al.
Biochemical and Biophysical Research Communications|August 16, 2014
Regulation of IL-6 and IL-8 production by reciprocal cell-to-cell interactions between tumor cells and stromal fibroblasts through IL-1α in ameloblastomaTakao Fuchigami, Toshiro Kibe, Hirofumi Koyama, et al.
Clinical and Translational Radiation Oncology|December 15, 2018
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancerKenta Onishi, Nobumichi Tanaka, Makito Miyake, et al.
Pageof 16